Highland Private Wealth Management Eli Lilly & CO Transaction History

Highland Private Wealth Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $40,914 - $46,626	138 Added 7.62%	1,950 $631,000
Q2 2022 Jul 14, 2022	BUY	$278.73 - $327.27 $44,039 - $51,708	158 Added 9.55%	1,812 $587,000
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $13,612 - $16,916	-58 Reduced 3.39%	1,654 $474,000
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $31,928 - $39,623	142 Added 9.04%	1,712 $473,000
Q3 2021 Oct 21, 2021	BUY	$221.6 - $272.71 $18,171 - $22,362	82 Added 5.51%	1,570 $363,000
Q2 2021 Aug 03, 2021	SELL	$180.55 - $233.54 $361 - $467	-2 Reduced 0.13%	1,488 $341,000
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $7,887 - $10,210	48 Added 3.33%	1,490 $278,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $3,391 - $4,488	26 Added 1.84%	1,442 $244,000
Q3 2020 Oct 08, 2020	BUY	$146.22 - $169.13 $14,768 - $17,082	101 Added 7.68%	1,416 $209,000
Q2 2020 Jul 21, 2020	BUY	$136.42 - $164.18 $179,392 - $215,896	1,315 New	1,315 $215,000

4,073

737M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Highland Private Wealth Management with notifications on news.